trial · primary record
Claseprubart
Myasthenia Gravis, Generalized
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 195 |
| Primary completion | 2031-09 |
| Primary endpoint | Change from Baseline to Week 17 in Myasthenia Gravis Activities of Daily Living (MG-ADL) Scale Score |
| Registry ID | NCT07647510 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:40:51.375Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07647510
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Claseprubart · compound